Category Specific RSS

News

Online transactions surge through COVID-19 lockdowns as Novatti acquires Emersion

As society is bunkered down in self-isolation to prevent the spread of COVID-19, fintech company Novatti (ASX: NOV) has acquired…

6 years ago

Opportunistic scammers use coronavirus to spread computervirus

Highly publicised tragedies always seem to summon the most despicable of fraudsters. To the rage of many, we saw during…

6 years ago

ResApp to launch wireless Sleep Apnoea diagnostics app

Australian medtech company ResApp (ASX: RAP) is set to make diagnosing sleep apnoea significantly easier for individuals with the launch…

6 years ago

Microcap solar farm builder MPower secures $4m contract to build another in S.A.

Despite trading on the ASX as a microcap, renewable energy company MPower (ASX: MPR) continues to execute a solid pipeline…

6 years ago

Testing confirms Archer’s high-value graphite for Li-ion batteries

Despite graphite being listed as a 'critical mineral' by global leaders, it is not currently produced in Australia. However, that…

6 years ago

Cyclopharm submits FDA application, expects 50% market share within 3 years

Australian medtech company Cyclopharm (ASX: CYC) is set to add the United States to the list of 59 countries which…

6 years ago

PM encourages allied healthcare providers to stay open – Here’s three on the ASX

Amidst the national lockdown to prevent the spread of COVID-19, the government has encouraged allied healthcare providers to remain open…

6 years ago

The post-coronavirus world – Could working from home become a norm?

With containment of COVID-19 being our global priority for 2020, one of the key themes to have emerged from the…

6 years ago

Travel ban bites as Virgin grounds 90% of fleet, stand down 80% of workforce

Following last night's national address by Prime Minister Scott Morrison, introducing an overseas travel ban, Virgin Australia (ASX: VAH) has…

6 years ago

Retired NFL players endorse Zilosul, Paradigm’s osteoarthritis drug trials

Professional athletes may soon have a new treatment for knee osteoarthritis after Paradigm Biopharmaceuticals (ASX: PAR) received glowing endorsements from…

6 years ago